CymaBay Therapeutics, Inc. Appoints Éric Lefebvre to the Audit Committee and the Nominating and Corporate Governance Committee of the Board

On March 11, 2022 the Board of Directors of CymaBay Therapeutics, Inc. appointed Éric Lefebvre to the Board, effective as of March 21, 2022. On April 15, 2022 the Board appointed Dr. Lefebvre to the Audit Committee and the Nominating and Corporate Governance Committee of the Board.